New Antibody Fragment Shows Promise in Treating Rare Form of Amyloidosis

Researchers have identified a potential treatment for light chain amyloidosis, offering hope to patients with this rare condition. The antibody fragment discovered could improve prognosis and lead to advancements in treating amyloid-related diseases like Alzheimer’s.